Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to demerge its pharmaceuticals business and simplify the corporate structure.
The company has received 99 per cent of votes at the shareholders meeting held on Tuesday, PEL said in a statement.
The demerger will divide the company into two focused entities —financial services and pharmaceuticals.
The company has received 99 per cent of votes at the shareholders meeting held on Tuesday, PEL said in a statement.
The demerger will divide the company into two focused entities —financial services and pharmaceuticals.